Literature DB >> 15504958

Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice.

Susann Blüher1, Stergios Moschos, John Bullen, Efi Kokkotou, Eleftheria Maratos-Flier, Stanley J Wiegand, Mark W Sleeman, Mark W Sleemann, Christos S Mantzoros.   

Abstract

Ciliary neurotrophic factor (CNTF) potently reduces appetite and body weight in rodents and humans. We studied the short- and long-term effects of CNTF(Ax15), a second-generation CNTF analog, in diet-induced obese C57BL/6J mice and brown adipose tissue (BAT)-deficient obese UCP1-DTA (uncoupling protein 1-diphtheria toxin A) mice. CNTF(Ax15) administration (0.1, 0.3, or 1.0 microg . g(-1) . day(-1) s.c.) for 3 or 7 days reduced food intake and body weight (mainly body fat mass). The effect of CNTF(Ax15) on food intake and body weight was more pronounced in CNTF(Ax15)-treated diet-induced obese C57BL/6J mice compared with pair-fed controls and was associated with suppressed expression of hypothalamic neuropeptide Y and agouti gene-related protein. Moreover, CNTF(Ax15) increased uncoupling protein 1 mRNA expression in BAT and energy expenditure in diet-induced obese C57BL/6J mice. Longitudinal observations revealed a sustained reduction in body weight for several days post-CNTF(Ax15) treatment of CNTF(Ax15)-treated but not pair-fed mice, followed by a gradual regain in body weight over 28 days. Finally, CNTF(Ax15) administration improved the metabolic profile in both diet-induced obese C57BL/6J and UCP1-DTA mice and resulted in a significantly improved glycemic response to oral glucose tolerance tests in CNTF(Ax15)-treated UCP1-DTA compared with pair-fed mice of similar body weight. These data suggest that CNTF(Ax15) may act through a pathway downstream of the putative point responsible for leptin resistance in diet-induced obese C57BL/6J and UCP1-DTA mice to alter food intake, body weight, body composition, and metabolism. CNTF(Ax15) has delayed and persistent effects in diet-induced obese C57BL/6J mice, which account for a reduction in body weight over and above what would be expected based on decreased foot intake alone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504958     DOI: 10.2337/diabetes.53.11.2787

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

1.  Research advances in metabolism 2016.

Authors:  Nikolaos Perakakis; Olivia M Farr; Dario Tuccinardi; Jagriti Upadhyay; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-11-06       Impact factor: 8.694

2.  Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet.

Authors:  X Liu; J Y Huh; H Gong; J P Chamberland; M T Brinkoetter; O-P R Hamnvik; C S Mantzoros
Journal:  Int J Obes (Lond)       Date:  2015-05-21       Impact factor: 5.095

3.  Ciliary neurotrophic factor (CNTF) protects non-obese Swiss mice against type 2 diabetes by increasing beta cell mass and reducing insulin clearance.

Authors:  L F Rezende; G J Santos; J C Santos-Silva; E M Carneiro; A C Boschero
Journal:  Diabetologia       Date:  2012-02-19       Impact factor: 10.122

4.  High fat induces acute and chronic inflammation in the hypothalamus: effect of high-fat diet, palmitate and TNF-α on appetite-regulating NPY neurons.

Authors:  P S Dalvi; J A Chalmers; V Luo; D-Yd Han; L Wellhauser; Y Liu; D Q Tran; J Castel; S Luquet; M B Wheeler; D D Belsham
Journal:  Int J Obes (Lond)       Date:  2016-10-24       Impact factor: 5.095

Review 5.  The gp130 receptor cytokine family: regulators of adipocyte development and function.

Authors:  Ursula A White; Jacqueline M Stephens
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  gp130 receptor ligands as potential therapeutic targets for obesity.

Authors:  Mark A Febbraio
Journal:  J Clin Invest       Date:  2007-04       Impact factor: 14.808

7.  Ciliary neurotrophic factor protects mice against streptozotocin-induced type 1 diabetes through SOCS3: the role of STAT1/STAT3 ratio in β-cell death.

Authors:  Luiz F Rezende; Gustavo J Santos; Everardo M Carneiro; Antonio C Boschero
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

8.  Oncostatin m is produced in adipose tissue and is regulated in conditions of obesity and type 2 diabetes.

Authors:  David Sanchez-Infantes; Ursula A White; Carrie M Elks; Ron F Morrison; Jeffrey M Gimble; Robert V Considine; Anthony W Ferrante; Eric Ravussin; Jacqueline M Stephens
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

Review 9.  CNTF: a target therapeutic for obesity-related metabolic disease?

Authors:  Vance B Matthews; Mark A Febbraio
Journal:  J Mol Med (Berl)       Date:  2008-01-22       Impact factor: 4.599

10.  Altered levels of adiponectin and adiponectin receptors may underlie the effect of ciliary neurotrophic factor (CNTF) to enhance insulin sensitivity in diet-induced obese mice.

Authors:  S Blüher; J Bullen; C S Mantzoros
Journal:  Horm Metab Res       Date:  2008-03       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.